# Lindblad Expeditions Holdings, Inc.: financial statements, quarterly

LIND · Nasdaq · CIK 1512499 · [Industrials](/sectors/industrials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/lind.md) · [Financials](/companies/lind/financials.md) · [Filings](/companies/lind/filings.md) · [Insiders](/companies/lind/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/lind/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [176](/filings/0001437749-24-033357.md) | [125 d](/filings/0001437749-26-005873.md) | [154](/filings/0001437749-25-014765.md) | [136](/filings/0001437749-25-024642.md) | [206](/filings/0001437749-25-033060.md) | [149 d](/filings/0001437749-26-005873.md) | [180](/filings/0001437749-26-014912.md) | [168](/filings/0001437749-26-025462.md) | [240](/filings/0001437749-25-033060.md) | [183 d](/filings/0001437749-26-005873.md) | [208](/filings/0001437749-26-014912.md) | [199](/filings/0001437749-26-025462.md) |
| Cost of revenue | $m | [95.6](/filings/0001437749-24-033357.md) | [92.9 d](/filings/0001437749-26-005873.md) | [84.5](/filings/0001437749-25-014765.md) | [83.0](/filings/0001437749-25-024642.md) | [110](/filings/0001437749-25-033060.md) | [85.4 d](/filings/0001437749-26-005873.md) | [92.8](/filings/0001437749-26-014912.md) | [91.4](/filings/0001437749-26-025462.md) | [124](/filings/0001437749-25-033060.md) | [109 d](/filings/0001437749-26-005873.md) | [107](/filings/0001437749-26-014912.md) | [103](/filings/0001437749-26-025462.md) |
| Gross profit | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Operating income | $m | [20.5](/filings/0001437749-24-033357.md) | [(13.8) d](/filings/0001437749-26-005873.md) | [7.9](/filings/0001437749-25-014765.md) | [(8.2)](/filings/0001437749-25-024642.md) | [29.5](/filings/0001437749-25-033060.md) | [(7.6) d](/filings/0001437749-26-005873.md) | [10.6](/filings/0001437749-26-014912.md) | [4.4](/filings/0001437749-26-025462.md) | [36.0](/filings/0001437749-25-033060.md) | [(5.5) d](/filings/0001437749-26-005873.md) | [15.6](/filings/0001437749-26-014912.md) | [12.0](/filings/0001437749-26-025462.md) |
| Interest expense | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | [0.0](/filings/0001437749-24-033357.md) | [1.6 d](/filings/0001437749-26-005873.md) | [0.2](/filings/0001437749-25-014765.md) | [4.5](/filings/0001437749-25-024642.md) | [(6.7)](/filings/0001437749-25-033060.md) | [5.2 d](/filings/0001437749-26-005873.md) | [(1.5)](/filings/0001437749-26-014912.md) | [0.5](/filings/0001437749-26-025462.md) | [(2.6)](/filings/0001437749-25-033060.md) | [6.0 d](/filings/0001437749-26-005873.md) | [(1.2)](/filings/0001437749-26-014912.md) | [1.4](/filings/0001437749-26-025462.md) |
| Net income | $m | [5.6](/filings/0001437749-24-033357.md) | [(27.4) d](/filings/0001437749-26-005873.md) | [(4.0)](/filings/0001437749-25-014765.md) | [(24.7)](/filings/0001437749-25-024642.md) | [22.5](/filings/0001437749-25-033060.md) | [(25.0) d](/filings/0001437749-26-005873.md) | [1.2](/filings/0001437749-26-014912.md) | [(8.5)](/filings/0001437749-26-025462.md) | [1.2](/filings/0001437749-25-033060.md) | [(23.6) d](/filings/0001437749-26-005873.md) | [6.5](/filings/0001437749-26-014912.md) | [(1.4)](/filings/0001437749-26-025462.md) |
| Diluted EPS | $ per share | [0.08](/filings/0001437749-24-033357.md) | not reported | [(0.10)](/filings/0001437749-25-014765.md) | [(0.48)](/filings/0001437749-25-024642.md) | [0.36](/filings/0001437749-25-033060.md) | not reported | [0.00](/filings/0001437749-26-014912.md) | [(0.18)](/filings/0001437749-26-025462.md) | [0.00](/filings/0001437749-25-033060.md) | not reported | [0.09](/filings/0001437749-26-014912.md) | [(0.02)](/filings/0001437749-26-025462.md) |
| Basic EPS | $ per share | [0.08](/filings/0001437749-24-033357.md) | not reported | [(0.10)](/filings/0001437749-25-014765.md) | [(0.48)](/filings/0001437749-25-024642.md) | [0.39](/filings/0001437749-25-033060.md) | not reported | [0.00](/filings/0001437749-26-014912.md) | [(0.18)](/filings/0001437749-26-025462.md) | [0.00](/filings/0001437749-25-033060.md) | not reported | [0.10](/filings/0001437749-26-014912.md) | [(0.02)](/filings/0001437749-26-025462.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
- Cost of revenue: us-gaap:CostOfRevenue
- Gross profit: not reported
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: not reported
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [168](/filings/0001437749-24-033357.md) | [157](/filings/0001437749-26-005873.md) | [178](/filings/0001437749-25-014765.md) | [168](/filings/0001437749-25-024642.md) | [194](/filings/0001437749-25-033060.md) | [184](/filings/0001437749-26-005873.md) | [189](/filings/0001437749-26-014912.md) | [201](/filings/0001437749-26-025462.md) | [262](/filings/0001437749-25-033060.md) | [257](/filings/0001437749-26-025462.md) | [275](/filings/0001437749-26-014912.md) | [319](/filings/0001437749-26-025462.md) |
| Current assets | $m | [259](/filings/0001437749-23-030025.md) | [245](/filings/0001437749-25-005544.md) | [287](/filings/0001437749-24-014073.md) | [284](/filings/0001437749-24-025584.md) | [288](/filings/0001437749-24-033357.md) | [278](/filings/0001437749-26-005873.md) | [296](/filings/0001437749-25-014765.md) | [323](/filings/0001437749-25-024642.md) | [364](/filings/0001437749-25-033060.md) | [368](/filings/0001437749-26-025462.md) | [385](/filings/0001437749-26-014912.md) | [443](/filings/0001437749-26-025462.md) |
| Total assets | $m | [852](/filings/0001437749-23-030025.md) | [831](/filings/0001437749-25-005544.md) | [868](/filings/0001437749-24-014073.md) | [858](/filings/0001437749-24-025584.md) | [890](/filings/0001437749-24-033357.md) | [877](/filings/0001437749-26-005873.md) | [909](/filings/0001437749-25-014765.md) | [937](/filings/0001437749-25-024642.md) | [977](/filings/0001437749-25-033060.md) | [980](/filings/0001437749-26-025462.md) | [987](/filings/0001437749-26-014912.md) | [1,034](/filings/0001437749-26-025462.md) |
| Current liabilities | $m | [319](/filings/0001437749-23-030025.md) | [319](/filings/0001437749-25-005544.md) | [358](/filings/0001437749-24-014073.md) | [383](/filings/0001437749-24-025584.md) | [386](/filings/0001437749-24-033357.md) | [392](/filings/0001437749-26-005873.md) | [421](/filings/0001437749-25-014765.md) | [450](/filings/0001437749-25-024642.md) | [439](/filings/0001437749-25-033060.md) | [462](/filings/0001437749-26-025462.md) | [473](/filings/0001437749-26-014912.md) | [525](/filings/0001437749-26-025462.md) |
| Total liabilities | $m | [943](/filings/0001437749-23-030025.md) | [945](/filings/0001437749-25-005544.md) | [984](/filings/0001437749-24-014073.md) | [1,014](/filings/0001437749-24-025584.md) | [1,012](/filings/0001437749-24-033357.md) | [1,022](/filings/0001437749-26-005873.md) | [1,050](/filings/0001437749-25-014765.md) | [1,081](/filings/0001437749-25-024642.md) | [1,105](/filings/0001437749-25-033060.md) | [1,133](/filings/0001437749-26-025462.md) | [1,144](/filings/0001437749-26-014912.md) | [1,196](/filings/0001437749-26-025462.md) |
| Long-term debt | $m | [621](/filings/0001437749-23-030025.md) | [622](/filings/0001437749-25-005544.md) | [623](/filings/0001437749-24-014073.md) | [624](/filings/0001437749-24-025584.md) | [625](/filings/0001437749-24-033357.md) | [625](/filings/0001437749-26-005873.md) | [626](/filings/0001437749-25-014765.md) | [627](/filings/0001437749-25-024642.md) | [663](/filings/0001437749-25-033060.md) | [663](/filings/0001437749-26-025462.md) | [663](/filings/0001437749-26-014912.md) | [664](/filings/0001437749-26-025462.md) |
| Current portion of debt | $m | [0.0](/filings/0001437749-23-030025.md) | [0.0](/filings/0001437749-25-005544.md) | [0.0](/filings/0001437749-24-014073.md) | [0.0](/filings/0001437749-24-025584.md) | [0.0](/filings/0001437749-24-033357.md) | [0.0](/filings/0001437749-26-005873.md) | [0.0](/filings/0001437749-25-014765.md) | [0.0](/filings/0001437749-25-024642.md) | [0.0](/filings/0001437749-25-033060.md) | [0.0](/filings/0001437749-26-025462.md) | [0.0](/filings/0001437749-26-014912.md) | [0.0](/filings/0001437749-26-025462.md) |
| Shareholders' equity | $m | [(198)](/filings/0001437749-24-033357.md) | [(225)](/filings/0001437749-26-005873.md) | [(227)](/filings/0001437749-25-024642.md) | [(255)](/filings/0001437749-25-033060.md) | [(227)](/filings/0001437749-25-033060.md) | [(253)](/filings/0001437749-26-025462.md) | [(252)](/filings/0001437749-26-025462.md) | [(264)](/filings/0001437749-26-025462.md) | [(257)](/filings/0001437749-25-033060.md) | [(285)](/filings/0001437749-26-025462.md) | [(190)](/filings/0001437749-26-025462.md) | [(196)](/filings/0001437749-26-025462.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [15.8 d](/filings/0001437749-24-033357.md) | [(9.9) d](/filings/0001437749-26-005873.md) | [43.9](/filings/0001437749-25-014765.md) | [18.7 d](/filings/0001437749-25-024642.md) | [28.1 d](/filings/0001437749-25-033060.md) | [1.7 d](/filings/0001437749-26-005873.md) | [48.4](/filings/0001437749-26-014912.md) | [29.2 d](/filings/0001437749-26-025462.md) | [19.5 d](/filings/0001437749-25-033060.md) | [14.4 d](/filings/0001437749-26-005873.md) | [49.5](/filings/0001437749-26-014912.md) | [59.1 d](/filings/0001437749-26-025462.md) |
| Capital expenditure | $m | [8.0 d](/filings/0001437749-24-033357.md) | [7.2 d](/filings/0001437749-26-005873.md) | [6.5](/filings/0001437749-25-014765.md) | [7.4 d](/filings/0001437749-25-024642.md) | [9.8 d](/filings/0001437749-25-033060.md) | [9.9 d](/filings/0001437749-26-005873.md) | [13.4](/filings/0001437749-26-014912.md) | [15.7 d](/filings/0001437749-26-025462.md) | [7.6 d](/filings/0001437749-25-033060.md) | [11.0 d](/filings/0001437749-26-005873.md) | [6.9](/filings/0001437749-26-014912.md) | [8.0 d](/filings/0001437749-26-025462.md) |
| Share repurchases | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Share repurchases: not reported

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [53.0](/filings/0001437749-23-030025.md) | [53.1](/filings/0001437749-24-014073.md) | [53.2](/filings/0001437749-24-025584.md) | [53.4](/filings/0001437749-24-033357.md) | [53.4](/filings/0001437749-25-014765.md) | [53.5](/filings/0001437749-25-024642.md) | [62.6](/filings/0001437749-25-033060.md) | [54.6](/filings/0001437749-26-014912.md) | [54.6](/filings/0001437749-26-025462.md) | [55.6](/filings/0001437749-25-033060.md) | [61.1](/filings/0001437749-26-014912.md) | [65.5](/filings/0001437749-26-025462.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 65,619,689 at 2026-07-27, from the cover of the [10-Q filed 2026-08-03](/filings/0001437749-26-025462.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:41 ET. No prices; not investment advice.